Page last updated: 2024-09-03

rhenium-186 hedp and technetium tc 99m medronate

rhenium-186 hedp has been researched along with technetium tc 99m medronate in 4 studies

Compound Research Comparison

Studies
(rhenium-186 hedp)
Trials
(rhenium-186 hedp)
Recent Studies (post-2010)
(rhenium-186 hedp)
Studies
(technetium tc 99m medronate)
Trials
(technetium tc 99m medronate)
Recent Studies (post-2010) (technetium tc 99m medronate)
7532194,609181549

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Franke, WG; Hliscs, R; Kropp, J; Liepe, K1
Brenner, W; Brümmer, C; Czech, N; Henze, E; Kampen, WU; Muhle, C; von Forstner, C; Zuhayra, M1
Binnie, D; Dearnaley, D; Divoli, A; Flux, G; McCready, VR1
Alsharif, A; Boni, G; Borsò, E; Chiacchio, S; Greco, C; Grosso, M; Lorenzoni, A; Manca, G; Mariani, G; Mazzarri, S; Nyakale, N; Volterrani, D1

Reviews

1 review(s) available for rhenium-186 hedp and technetium tc 99m medronate

ArticleYear
Radionuclide therapy and integrated protocols for bone metastases.
    The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2011, Volume: 55, Issue:4

    Topics: Bone Neoplasms; Combined Modality Therapy; Diphosphonates; Drug Therapy, Combination; Etidronic Acid; Humans; Organometallic Compounds; Organophosphorus Compounds; Pain; Palliative Care; Patient Selection; Radioimmunotherapy; Radiopharmaceuticals; Technetium Tc 99m Medronate; Treatment Outcome

2011

Other Studies

3 other study(ies) available for rhenium-186 hedp and technetium tc 99m medronate

ArticleYear
Significant reduction of the mass of bone metastasis 1 year after rhenium-186 HEDP pain palliation therapy.
    Clinical nuclear medicine, 2000, Volume: 25, Issue:11

    Topics: Bone Neoplasms; Etidronic Acid; Humans; Male; Middle Aged; Organometallic Compounds; Pain; Palliative Care; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Technetium Tc 99m Medronate

2000
Bone uptake studies in rabbits before and after high-dose treatment with 153Sm-EDTMP or 186Re-HEDP.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2003, Volume: 44, Issue:2

    Topics: Animals; Bone and Bones; Connective Tissue; Etidronic Acid; Female; Organometallic Compounds; Organophosphorus Compounds; Rabbits; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Technetium Tc 99m Medronate; Urinary Bladder; Whole-Body Counting

2003
The potential use of 99mTc-MDP bone scans to plan high-activity 186Re-HEDP targeted therapy of bony metastases from prostate cancer.
    Cancer biotherapy & radiopharmaceuticals, 2005, Volume: 20, Issue:2

    Topics: Bone and Bones; Bone Neoplasms; Etidronic Acid; Humans; Image Processing, Computer-Assisted; Male; Neoplasm Metastasis; Organometallic Compounds; Prostatic Neoplasms; Radioimmunodetection; Radioisotopes; Radiopharmaceuticals; Software; Technetium Tc 99m Medronate; Time Factors; Whole-Body Counting

2005